These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24762272)

  • 1. Novel products for haemostasis.
    Shima M; Hermans C; de Moerloose P
    Haemophilia; 2014 May; 20 Suppl 4():29-35. PubMed ID: 24762272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
    Shirahata A; Fukutake K; Takamatsu J; Shima M; Hanabusa H; Mugishima H; Amano K; Takedani H; Tamashima S; Matsushita T; Tawa A; Tanaka I; Higasa S; Kosaka Y; Fujii T; Sakai M; Migita M; Kawakami K; Ohashi Y; Saito H
    Haemophilia; 2013 Nov; 19(6):853-60. PubMed ID: 23738888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel products for haemostasis - current status.
    Oldenburg J; Albert T
    Haemophilia; 2014 May; 20 Suppl 4():23-8. PubMed ID: 24762271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors--phase I trial.
    Shirahata A; Fukutake K; Mimaya J; Takamatsu J; Shima M; Hanabusa H; Takedani H; Takashima Y; Matsushita T; Tawa A; Higasa S; Takata N; Sakai M; Kawakami K; Ohashi Y; Saito H
    Haemophilia; 2012 Jan; 18(1):94-101. PubMed ID: 21535327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA; Freedman J; Semple JW
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current status and trends in blood biologicals].
    Wang Z; Zhao X; Lv M; Zhang J
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):730-46. PubMed ID: 21845840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.
    Shinkoda Y; Shirahata A; Fukutake K; Takamatsu J; Shima M; Hanabusa H; Mugishima H; Takedani H; Kawasugi K; Taki M; Matsushita T; Tawa A; Nogami K; Higasa S; Kosaka Y; Fujii T; Sakai M; Migita M; Uchiba M; Kawakami K; Sameshima K; Ohashi Y; Saito H
    Haemophilia; 2017 Jan; 23(1):59-66. PubMed ID: 27480904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.
    Den Uijl I; Mauser-Bunschoten EP; Roosendaal G; Schutgens R; Fischer K
    Haemophilia; 2009 Nov; 15(6):1215-8. PubMed ID: 19686467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of rare factor deficiencies in 2016.
    Peyvandi F; Menegatti M
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):663-669. PubMed ID: 27913544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study.
    Spira J; Plyushch O; Zozulya N; Yatuv R; Dayan I; Bleicher A; Robinson M; Baru M
    Haemophilia; 2010 Nov; 16(6):910-8. PubMed ID: 20491957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the treatment of inherited coagulation disorders.
    Escobar MA
    Haemophilia; 2013 Sep; 19(5):648-59. PubMed ID: 23600951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the treatment of bleeding disorders.
    Peyvandi F; Garagiola I; Biguzzi E
    J Thromb Haemost; 2016 Nov; 14(11):2095-2106. PubMed ID: 27590165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
    Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
    Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors--phase I trial: 2nd report.
    Shirahata A; Fukutake K; Mimaya J; Takamatsu J; Shima M; Hanabusa H; Takedani H; Takashima Y; Matsushita T; Tawa A; Higasa S; Takata N; Sakai M; Kawakami K; Ohashi Y; Saito H
    Haemophilia; 2013 Mar; 19(2):330-7. PubMed ID: 22989180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical issues in inhibitors.
    Astermark J; Santagostino E; Keith Hoots W
    Haemophilia; 2010 Jul; 16 Suppl 5():54-60. PubMed ID: 20590857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
    Valentino LA
    Haemophilia; 2009 May; 15(3):733-42. PubMed ID: 19298380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapies for haemophilia - Global perspective.
    Mahlangu J; Cerquiera M; Srivastava A
    Haemophilia; 2018 May; 24 Suppl 6():15-21. PubMed ID: 29878661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of bypassing agents for hemophilia with inhibitors in the era of novel agents.
    Shapiro AD; Mitchell IS; Nasr S
    J Thromb Haemost; 2018 Dec; 16(12):2362-2374. PubMed ID: 30264916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of haemophilia A.
    Gringeri A; Muça-Perja M; Mangiafico L; von Mackensen S
    Expert Opin Biol Ther; 2011 Aug; 11(8):1039-53. PubMed ID: 21682657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.